1. CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation

   Liu, B., Diaz Arguello, O. A., Chen, D., Chen, S., Saber, A. & Haisma, H. J., 15-May-2020, In : PLoS ONE. 15, 5, 13 p., e0232985.

   Research output: Contribution to journal › Article › Academic › peer-review

2. A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL

   Zhang, B., Chen, D., Liu, B., Dekker, F. J. & Quax, W. J., May-2020, In : Biochemical Pharmacology. 175, 10 p., 113914.

   Research output: Contribution to journal › Article › Academic › peer-review

3. A bispecific inhibitor of the EGFR/ADAM17 axis decreases cell proliferation and migration of EGFR-dependent cancer cells

   Soto-Gamez, A., Chen, D., Nabuurs, A. G. E., Quax, W. J., Demaria, M. & Boersma, Y. L., Feb-2020, In : Cancers. 12, 2, 14 p., 411.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Structure-activity relationships for binding of 4-substituted triazole-phenols to macrophage migration inhibitory factor (MIF)

   Xiao, Z., Fokkens, M., Chen, D., Kok, T., Proietti, G., Van Merkerk, R., Poelarends, G. J. & Dekker, F. J., 15-Jan-2020, In : European Journal of Medicinal Chemistry. 186, 13 p., 111849.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing

   Liu, B., Chen, S., Chen, D., Cao, F., Zwinderman, M., Kiemel, D., Aïssi, M., Dekker, F. J., Haisma, H. J. & La Rose, A., 24-Jan-2020, In : Nucleic Acids Research. 48, 2, p. 517-532 16 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (5) »